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2 
Abstract 33 
Embryo transfer (ET) in mice is a key technique in biomedical research, and is 34 
carried out mostly via surgery by transferring founder embryos into pseudo-pregnant 35 
recipient females. To cover post-operative analgesic requirements in surrogate 36 
mothers, oral self-administration of painkillers has several advantages, but its 37 
effectiveness has also been criticized as voluntary ingestion of the drug can be 38 
uncertain. Additionally, concerns about potential negative side effects of analgesics 39 
on embryo viability and development have been raised. In this regard, we 40 
investigated the impact of orally administered analgesia by comparing the outcome 41 
of ET with and without paracetamol in the drinking water (3.5 mg/ml) of surrogate 42 
mothers. Water intake increased significantly when paracetamol, as a sweet-tasting 43 
formulation (children’s syrup), was added to the drinking water. Measurements of 44 
paracetamol concentrations in blood serum confirmed reasonable drug uptake. 45 
Success rate of ETs and the body weight of newborn offspring were not different 46 
whether paracetamol was administered for two days after surgery or not. In 47 
conclusion, paracetamol in drinking water was consumed voluntarily in substantial 48 
doses, without detectable side-effects, by freshly operated surrogate mothers, and 49 
can therefore be recommended as a feasible method for providing analgesic 50 
treatment for surgical ET in mice. 51 
52 
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1. Introduction58 
The transfer of isolated embryos into pseudo-pregnant surrogate mothers 59 
represents a basic routine procedure for establishing new genetically modified 60 
mouse lines, and is used routinely for rederivation of pathogen-contaminated lines 61 
or revitalization of archived strains. Embryo transfer (ET) in mice is commonly 62 
conducted by a surgical approach (Nagy et al., 2003). Therefore, a laparotomy is 63 
performed, i.e. the abdominal cavity is opened under sterile conditions, and the 64 
oviduct or uterus horns are exposed for the transfer of embryos, aided by visual 65 
control using a microscope. Surgical ET is performed under general anaesthesia, 66 
and intra- as well as post-operative pain relief in animals undergoing such invasive 67 
surgery is an essential refinement to avoid unnecessary pain and suffering of the 68 
affected animals. 69 
Recently, new ET techniques, avoiding the need for surgery and post-operative pain 70 
treatment, have been published (Bin Ali et al., 2014; Cui et al., 2014; Steele et al., 71 
2013). In these procedures, embryos (only blastocysts are recommended) are 72 
transferred with specialized instruments through the cervix into the uterine horn in 73 
conscious surrogate mothers. Although the specifically designed devices required 74 
are already available on the market, most laboratories prefer a surgical approach, 75 
as it allows for reliable evidence of pseudo-pregnancy by the direct observation of 76 
a swollen ampulla or corpora lutea in recipient ovaries. Furthermore, the accurate 77 
transfer of the appropriate developmental stages into the oviduct or uterus horns 78 
can be confirmed visually. Surgical ET has proven to be a reliable and efficient 79 
technique for decades. However, when a surgical approach is chosen, post-80 
interventional analgesia needs to be applied for alleviation of post-operative pain, 81 
which can persist for 1–2 days after surgery. The choice of an appropriate pain 82 
control should take into account an easy and reliable mode of application, preferably 83 
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with the longest possible analgesic affect, but without any negative effects on 84 
embryo development or gestation. 85 
Regarding any potential influence on the success rate of ET, different effects have 86 
been reported for opioid analgesics. While morphine treatment hampered blastocyst 87 
implantation and decreased uterine receptivity (Tang et al., 2015), administering a 88 
single dose of buprenorphine during ET surgery did not increase embryonic loss 89 
compared to untreated animals (Goulding et al., 2010), and the number of 90 
successfully implanted embryos was even greater compared to untreated mice 91 
(Krueger and Fujiwara, 2008). Also, application of tramadol after ET in mice did not 92 
affect success rate outcomes, and may even have improved pup survival as birth 93 
rates and body weight in animals receiving tramadol did not differ from untreated 94 
animals, whereas the number of offspring was slightly increased in animals treated 95 
with this type of analgesic (Koutroli et al., 2014). 96 
Non-steroidal anti-inflammatory drugs (NSAIDs) are generally not recommended for 97 
pain treatment during pregnancy (Nolan, 2000). However, in mice, flunixin treatment 98 
was not associated with increased embryonic loss after ET (Goulding et al., 2010). 99 
In another study, application of tolfenamic acid or flunixin led to a higher pregnancy 100 
rate and higher numbers of offspring than in animals undergoing ET without 101 
analgesic treatment (Schlapp et al., 2015). A report on multimodal analgesia 102 
(recipient female mice received carprofen together with buprenorphine) also 103 
showed no significant adverse effects on the results of ET in mice (Parker et al., 104 
2011). 105 
Besides potential side-effects on gestation and embryo development, duration of 106 
analgesic action and route of application are the main criteria when choosing an 107 
appropriate pain relief protocol for mice. In small rodents, analgesics are applied 108 
mainly by intraperitoneal (i.p.) or subcutaneous (s.c.) injection. With opioids, 109 
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however, the duration of action is rather short, and injections have to be repeated 110 
several times per day to ensure constant analgesic efficacy (Jirkof et al., 2015). 111 
Some NSAIDs are known to induce longer lasting pain relief compared to opioids 112 
and may need to be injected only once or twice per day (Flecknell, 1984; Miller and 113 
Richardson, 2011). However, mice generally experience stress in response to 114 
immobilization and injections (Cinelli et al., 2007; Meijer et al., 2005; Meijer et al., 115 
2006). Therefore, oral self-medication represents a promising alternative to provide 116 
stress-free post-operative analgesia. The advantages of oral self-administration via 117 
drinking water (or food items) are the considerable reduction in stress and potential 118 
pain that might be caused by handling and restraining of mice with fresh wounds. 119 
However, food neophobia, where animals abstain from the consumption of 120 
unfamiliar substances or food, is a well-known behaviour in small rodents (Bauer et 121 
al., 2003). Moreover, food or water intake can be decreased after surgery, thus 122 
latency to consume analgesics voluntary could be prolonged, resulting in insufficient 123 
post-operative pain relief. Consequently, when adding drugs to food or drinking 124 
water, it is advisable to examine whether sufficient amounts of the medicated food 125 
or water are in fact consumed voluntarily over time. 126 
In human medicine, paracetamol (acetaminophen) has become a popular and 127 
widely used non-opioid drug for treatment of fever, as well as for acute and chronic 128 
pain management (Allegaert et al., 2014; Mattia and Coluzzi, 2009; Raffa et al., 129 
2004). While the mechanism of action remains partly unknown, selective inhibition 130 
of cyclooxygenase enzymes, as well as interaction with endogenous opioid 131 
pathways are unique features of paracetamol. Paracetamol is considered to have 132 
analgesic and antipyretic, rather than anti-inflammatory, effects compared to typical 133 
NSAIDs (Mattia and Coluzzi, 2009). Its intake in therapeutic dosages is generally 134 
regarded as safe in a variety of patients, also in pregnant women, where the use of 135 
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other NSAIDs is contraindicated due to potential risk to the unborn child 136 
(Aminoshariae and Khan, 2015). However, when overdosed, paracetamol can 137 
cause liver injuries, triggered by the hepatotoxic effect of its metabolites (Mattia and 138 
Coluzzi, 2009). 139 
Paracetamol is also recommended for pain relief in laboratory animals (Flecknell, 140 
1984; Miller and Richardson, 2011). Acetaminophen was shown to increase the pain 141 
threshold in rats (Mickley et al., 2006) and to be effective on bone cancer pain (Saito 142 
et al., 2005) or to show a potent, synergistic effect when combined with morphine or 143 
NSAIDs in mice (Miranda et al., 2006; Saito et al., 2005). The drug can be 144 
administered easily by various routes, e.g. by adding to drinking water (Hayes et al., 145 
2000; Mickley et al., 2006). This makes it an ideal drug for broad application in 146 
laboratories when opioids are not considered necessary, or are not available. 147 
In the present study, we investigated the analgesic paracetamol as a means of pain 148 
management after surgical ET in mice by adding it to the drinking water. The aim of 149 
the present study was to determine whether paracetamol in drinking water would be 150 
taken up voluntarily by mice in amounts sufficient to cover post-operative analgesic 151 
requirements after laparotomy without any detrimental effect on the ET success 152 
rate. 153 
 154 
2. Materials and Methods 155 
2.1. Ethics statement 156 
Animal housing and the experimental protocols were approved by the Cantonal 157 
Veterinary Office, Zurich, Switzerland, and were in accordance with Swiss Animal 158 
Protection Law. Housing and experimental procedures were also conform to 159 
European Directive 2010/63/EU of the European Parliament, and of the Council of 160 
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22 September 2010 on the Protection of Animals used for Scientific Purposes and 161 
to the Guide for the Care and Use of Laboratory Animals (2010/63/EU, 2010; 162 
Balinger et al., 2011). 163 
A preliminary investigation was undertaken to exclude adverse effects of a 164 
standardized pain treatment protocol with paracetamol in surrogate mothers during 165 
ET. Later, at the request of animal welfare officers and authorities, further 166 
investigation was performed to confirm the usefulness and reliability of the 167 
administration route, i.e. offering the drug for voluntary uptake. Mice used in the 168 
present study were surplus animals from our in-house breeding colony. To reduce 169 
animal numbers, no dose response studies or analgesiometric testing were 170 
conducted. Since experiments were performed at different time points, surrogate 171 
mothers or naïve female mice involved in the study varied with respect to their 172 
genetic background, i.e. mice of different outbred stocks were used in the two parts 173 
of the study. 174 
 175 
2.2. Animals and housing conditions 176 
The animal facility provided standardized housing conditions, with a mean room 177 
temperature of 21 ± 1°C, relative humidity of 50 ± 5%, and 15 complete changes of 178 
filtered air per hour (HEPA H 14 filter); air pressure was controlled at 50 Pa. The 179 
light/dark cycle in the animal rooms was set to a 12h/12h cycle (lights on at 07:00, 180 
lights off at 19:00) with artificial light of approximately 40 Lux in the cage. Mice were 181 
housed in a barrier-protected specific pathogen-free unit and were kept in 182 
Eurostandard Type III open-top plastic cages (425 mm × 266 mm × 155 mm, floor 183 
area 820 qcm; Techniplast, Indulab, Gams, Switzerland) with autoclaved dust-free 184 
sawdust bedding (80–90 g per cage, LTE E-001 Abedd; Indulab, Gams, 185 
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Switzerland). A standard cardboard house (Ketchum Manufacturing, Brockville, 186 
Canada) served as a shelter, and tissue papers were provided as nesting material. 187 
The animals had unrestricted access to sterilized drinking water, and ad libitum 188 
access to a pelleted and extruded mouse diet in the food hopper (Kliba No. 3436; 189 
Provimi Kliba, Kaiseraugst, Switzerland). To avoid any possible interference from 190 
external factors, all necessary husbandry and management procedures were 191 
completed in the room at least 1 day before starting the experiment, and 192 
disturbances (e.g., unrelated experimental procedures) were not allowed. 193 
The specific pathogen-free status of the animals was monitored frequently and 194 
confirmed according to FELASA guidelines throughout the experiments by a 195 
sentinel program. The mice were free of all viral, bacterial, and parasitic pathogens 196 
listed in FELASA recommendations (Mahler et al., 2015). 197 
For measurements of water intake and paracetamol concentrations in blood serum, 198 
40 female, naïve Crl:CD-1 mice, 8–16 weeks old, were used. Naïve mice were 199 
housed in groups of four to eight prior to the study. During baseline measurements 200 
and experiments mice were housed individually. 201 
To determine the impact of paracetamol on the outcome of ET, 15 female Zbz:FM 202 
mice were used as embryo recipients. The surrogate mothers were 8–16 weeks old 203 
when ET was performed. They were housed in groups of two to six animals until 204 
mating with vasectomized Zbz:FM males. Mating took place between 16:00 to 17:00 205 
to induce pseudo-pregnancy. Vaginal plug positive females were isolated on the 206 
next morning and subsequently housed individually. Two-cell stage embryos were 207 
obtained after standard superovulation of B6D2F1 females, mated with Zbz:FM 208 
males according to standard protocols (Rulicke, 2004). Briefly, female mice were 209 
treated at about 16:00 by intraperitoneal injection of 5 IU pregnant mare serum 210 
gonadotrophin (PMSG, Folligon; Intervet, Boxmeer, the Netherlands), followed 48 211 
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hrs later by 5 IU human chorionic gonadotrophin (hCG, Pregnyl; Organon AG, 212 
Pfäffikon SZ, Switzerland) and mated. About 40 hrs later, treated females were killed 213 
by cervical dislocation and two-cell embryos were flushed from both excised 214 
oviducts; embryos were stored in an incubator at 37°C, 5% CO2 in air using M16 215 
medium (Sigma-Aldrich, St. Louis, Missouri, USA) until embryo transfer on the same 216 
day. 217 
 218 
2.3. Experiment set up and data acquisition 219 
The schedule for the experimental procedure of both parts of the study is shown in 220 
Fig. 1. 221 
 222 
2.3.1. Naïve mice: Water intake and paracetamol in blood serum 223 
 224 
Treatment groups: 225 
Forty naïve female mice were randomly allocated into five groups, each group 226 
consisting of eight animals: three groups received paracetamol in the drinking water 227 
(PW 1–3). In order to compare serum concentrations between voluntary uptake in 228 
drinking water and other ascertained administration routes, two further groups 229 
received paracetamol either via oral gavage (group G) or via i.p. injection (group I). 230 
These two groups, with paracetamol administered as bolus, served as control 231 
groups. 232 
 233 
Treatment protocol: 234 
Paracetamol was provided in the drinking water according to the recommended 235 
published dosage (Flecknell, 2009; Miller and Richardson, 2011). The amount of 236 
paracetamol in drinking water was calculated with the intention to provide the mice 237 
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with 200 mg/kg body weight (BW) paracetamol over 24 hrs. Assuming that the water 238 
consumption of adult outbred mice is at least 3 ml per day, 28 ml paracetamol syrup, 239 
formulated to be applied per orally in children (Dafalgan® Children’s Syrup, 30 240 
mg/ml; Bristol-Myers Squibb SA, Steinhausen, Switzerland) was diluted in 212 ml 241 
tap water, resulting in a final concentration of 3.5 mg paracetamol per ml drinking 242 
water. One hour after onset of the light phase (08:00), mice were provided with a 243 
freshly prepared bottle of paracetamol-containing water for 6 hrs (group PW1), 11 244 
hrs (group PW2) or 24 hrs (group PW3). 245 
In control group G, the same dose of paracetamol (200 mg/kg BW) (Dafalgan® 246 
Children’s Syrup, 30 mg/ml; Bristol-Myers Squibb SA, Steinhausen, Switzerland) 247 
was given at 12:00 per gavage as bolus with a tube directly into the stomach of the 248 
mice. In control group I, the same dose of paracetamol (200 mg/kg BW) was given 249 
i.p. at 12:00 by using a formulation intended for injection delivery (Perfalgan®, 500 250 
mg/ml; Bristol-Myers Squibb SA, Steinhausen, Switzerland). Mice in the control 251 
groups were provided with untreated drinking water ad libitum. 252 
 253 
Water intake: 254 
Water intake was determined by weighing the drinking bottle at 6 hrs (PW1), 11 hrs 255 
(PW2) and 24 hrs (PW3) after provision of paracetamol-containing water (day 1). 256 
Baseline measurements of water intake without paracetamol in the drinking water 257 
were taken in the same mice at the identical time points the day before (day 0) (Fig. 258 
1). 259 
 260 
Blood sampling and paracetamol serum concentration measurements: 261 
In groups PW1–3, blood was sampled once per animal, either at 6 hrs (14:00; PW1), 262 
11 hrs (19:00; PW2), or 24 hrs (08:00; PW3) after paracetamol was provided for 263 
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voluntary intake with drinking water. In control groups I and G, blood was sampled 264 
at 2 hrs (14:00) after administering paracetamol in a single dose via gavage (G) or 265 
i.p. injection (I). All mice were bled under sevoflurane anaesthesia and killed after 266 
the procedure. Blood was centrifuged and the serum stored at –20°C until further 267 
analysis. Paracetamol serum concentrations were determined by DRI® 268 
Paracetamol-Serum-Tox-Assay by our in-house laboratory (Institute for Clinical 269 
Chemistry, University Hospital Zurich, Switzerland). 270 
 271 
 272 
2.3.2. Surrogate mothers: Water intake and reproductive parameters 273 
 274 
Treatment groups: 275 
Fifteen female mice were randomly allocated to either the untreated (n=8) or the 276 
paracetamol treated (n=7) group. 277 
 278 
Embryo transfer procedure: 279 
After monogamous mating with vasectomized males at 16:00 to 17:00 on the day 280 
prior to ET (day 0), females were checked for successful mating on the following 281 
morning (day 1) between 07:00 and 07:30 by vaginal plug control. Plug positive 282 
females were assumed to be pseudo-pregnant, and were housed individually in 283 
fresh cages. At 08:00 on day 1, they received either a fresh water bottle without 284 
medication (n=8) or a preemptive bottle with medicated drinking water (n=7) (Fig. 285 
1). 286 
At 13:00 on day 1, pseudo-pregnant females were transferred from the animal room 287 
to the nearby laboratory. Anaesthesia and ET were carried out in a biosafety 288 
cabinet, which was equipped with a water-bath-heated operating surface (38°C) and 289 
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an inhalation anaesthesia device, as described in detail previously (Rulicke, 2004). 290 
Briefly, anaesthesia was induced by restraining the mouse and holding its nose in a 291 
cone delivering Sevoflurane (≤8% in oxygen at a flow of 200 ml/min). After 15–292 
20 seconds, loss of protective reflexes was checked (e.g., pedal withdrawal reflex) 293 
and the back of the anesthetized animal was shaved and disinfected. 294 
ET was conducted bilaterally under aseptic conditions. The skin was cut in the 295 
midline of the back, the abdomen was opened by a small incision in the peritoneum 296 
near the ovary, and the reproductive tract was pulled out. Six two-cell stage embryos 297 
were transferred in M2 medium (Sigma-Aldrich, St. Louis, Missouri, USA) via the 298 
infundibulum in the ampulla on each side, so that each recipient received 12 299 
embryos. After placing the tract back in the abdominal cavity, the peritoneum was 300 
sutured with absorbable threads and the skin closed with staples. The anaesthetic 301 
gas was then stopped and 100% oxygen was supplied to the animal, which 302 
subsequently regained reflexes within 2–3 minutes and started to move away from 303 
the face mask. Anaesthesia and ET were completed within 15–20 minutes. The 304 
animal was allowed to recover for approximately 10 minutes on the warm surface in 305 
the biosafety hood, under a filter cup to prevent it escaping. After recovery, the 306 
mouse was returned to its cage and brought back to the animal room. Preparation 307 
of embryos, anaesthesia and ET was performed by the same technician, who was 308 
blinded to the treatment regimens. Animals of the untreated and treated groups were 309 
delivered in a randomized manner by the care taker to the lab technician each day. 310 
All ETs were completed within a week. 311 
 312 
Data acquisition in surrogate mothers: 313 
Water intake was determined at different time points as shown in Fig. 1. 314 
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Water bottles were weighed at 08:00 and 13:00 of day 1, at 08:00 of day 2 and at 315 
08:00 of day 3, i.e. 5, 24 and 48 hrs after starting the experiment. Surrogate mothers 316 
were monitored for pregnancy after 9 and 12 days of gestation by checking the 317 
appearance of the abdominal girth. From day 20 post coitum onwards, they were 318 
checked twice daily for birth, and offspring (including still births) were counted. All 319 
newborn offspring were weighed using an analytical balance within 12 hrs after birth, 320 
and counted daily until weaning at 21 days of age. 321 
 322 
2.4. Statistical analyses: 323 
Statistical analyses were performed using SPSS 22 software (IBM, Armonk, NY, 324 
USA). All data were tested for normal distribution and homogeneity of variance, and 325 
are presented as mean +/- standard deviation. 326 
Baseline and experimental water intake in ml/h of naïve mice was compared with a 327 
paired t-test. Water intake of surrogate mothers (in ml/h), as well as litter size and 328 
offspring weight after ET, were compared between treatment groups by independent 329 
t-tests. Mean serum concentrations of paracetamol were compared between 330 
different administration routes with one-way ANOVA. Post hoc analysis with the 331 
Games Howell test was carried out to identify significant differences between 332 
groups. Significance for all statistical tests was established at p ≤ 0.05. 333 
 334 
3. Results 335 
3.1. Intake of water with and without paracetamol in naïve mice and surrogate 336 
mothers 337 
Fluid intake in ml per hour in naïve mice with and without paracetamol in the drinking 338 
water is presented in Fig. 2. 339 
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During baseline measurements, naïve mice drank approximately 4.5 ± 1.46 ml per 340 
day in total. Water intake increased significantly when paracetamol was added to 341 
the drinking water. Intake of paracetamol-treated water versus untreated water was 342 
2.0 ± 0.74 ml vs. 1.2 ± 0.53 ml (p = 0.017) after 6 hrs, 3.4 ± 0.82 ml vs. 1.8 ± 0.13 343 
ml (p = 0.001) after 11 hrs, and 5.8 ± 1.40 ml vs. 3.6 ± 0.71 ml (p = 0.001) after 24 344 
hrs of administration. 345 
Fluid intake in ml per hour in surrogate mothers with and without paracetamol in the 346 
drinking water is shown in Fig. 3.  347 
Total intake of untreated water within the 5 hrs prior to ET varied between individual 348 
animals, ranging from 0.7 to 2.1 ml. The intake of paracetamol-containing water 349 
during this period ranged from 1.3 to 2.9 ml. The difference between both groups 350 
was non-significant preemptive to ET (p = 0.243). Total water intake after surgery 351 
was notably higher with paracetamol treatment, with a significant increase during 352 
the first (6–24 hrs, p = 0.023) and the second (24–48 hrs, p = 0.008) day after ET. 353 
 354 
3.2. Estimated paracetamol intake calculated from water intake 355 
From the amount of paracetamol-containing water consumed by naïve mice, the 356 
following consequential doses can be calculated: group PW1 mice consumed 104–357 
357 mg/kg BW (mean 208 ± 90) paracetamol within 6 hrs. In the first 6 hrs, five mice 358 
consumed less than the target dose of 200 mg/kg BW, namely 104–177 mg/kg BW, 359 
whereas three mice consumed more than the target dose. In group PW 2, mice 360 
consumed 273–506 mg/kg BW (mean 351 ± 85) paracetamol within 11 hrs, i.e. all 361 
group PW2 mice consumed more than the target dose. In group PW3, mice 362 
consumed 331–636 mg/kg BW (mean 517 ± 106) paracetamol within 24 hrs, and 363 
calculated doses exceeded target dose of 200 mg/kg BW in all mice. From the 364 
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amount of paracetamol-containing water consumed by surrogate mothers, the 365 
following consequential doses can be calculated: before ET started, doses of 366 
between 154 and 343 mg/kg BW were consumed within 5 hrs (mean 236 ± 68). Two 367 
out of 7 animals consumed doses less than 200 mg/kg BW prior to ET, namely 368 
154 mg/kg BW and 170 mg/kg BW. Following ET, in the remaining 18 hrs of day 1, 369 
the amount of paracetamol additionally consumed ranged from 379 to 766 mg/kg 370 
BW (mean 590 ± 123). On day 2 after ET, doses from 680 to 1077 mg/kg BW (mean 371 
820 ± 132) were consumed within 24 hrs. 372 
 373 
3.3. Serum paracetamol concentrations 374 
After 6 hrs, the mean serum concentration of naïve mice receiving paracetamol with 375 
drinking water (PW1) was 11.1 ± 3.0 µmol/L (1681.6 ± 460.1 ng/ml). Serum 376 
concentrations of naïve mice receiving paracetamol with drinking water were 377 
similarly increased after 11 h and 24 h (PW2: 18.3 ± 5.7 µmol/L, 2777.6 ± 870.0 378 
ng/ml; PW3: 18.5 ± 10.7 µmol/L, 2796.5 ± 1620.0 ng/ml). In control groups, the 379 
serum concentration was high 2 hrs after bolus application in the injection group (I), 380 
with 29.1 ± 8.14 µmol/L (4402.6 ± 1152.3 ng/ml), as well as in the gavage group (G) 381 
with 37.5 ± 14.60 µmol/L (5668.5 ± 2208.3 ng/ml). 382 
Mean serum concentrations differed significantly [F (4.35) = 9.85, p ≤ 0.0001]. Post 383 
hoc tests revealed significant differences between the i.p. injection group (I) and 384 
PW1 (p = 0.002), as well as between the gavage group (G) and PW1 (p = 0.008) 385 
and PW2 (p = 0.044). 386 
Individual serum concentrations of mice of different treatment groups are shown in 387 
Fig. 4. 388 
 389 
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3.4. Outcome from ET: comparison of reproductive parameters 390 
The results are summarized in Table 1. 391 
ET was successful in all surrogate mothers of the untreated group, i.e. without 392 
paracetamol in the drinking water. All mice became pregnant and delivered litters of 393 
2–6 pups (chronological order: 6, 5, 3, 2, 3, 6, 6, 4). 394 
In the paracetamol-treated group, one recipient was detected not to be pregnant at 395 
day 9 and 12 of gestation. We assume that pseudo-pregnancy in this female, 396 
although with a vaginal plug, had not been appropriately induced. However, this 397 
negative result was included for calculations and analysis. The remaining 6 398 
recipients of the paracetamol-treated group delivered litters of 3–8 pups 399 
(chronological order: 8, 3, 6, 6, 6, 3). The treated surrogate mothers delivered on 400 
average slightly more pups per litter; however, differences in the final success of ET 401 
were not significant (p = 0.864). 402 
The body weight of newborns was not significantly different between the two groups 403 
(p = 0.330). No dead offspring (or parts of pups) were found in cages around the 404 
time of birth, and all pups were reared and developed well, i.e. no losses or 405 
aberrations of growth or health were noticed at weaning. 406 
 407 
4. Discussion 408 
This study found no evidence of adverse effects on gestation or embryonic 409 
development after administration of 3.5 mg paracetamol per ml drinking water for 410 
2 days post-surgery. Interestingly, the water intake of surrogate mothers and naïve 411 
mice increased when paracetamol was added to the drinking water in the form of a 412 
children’s syrup. Measurements of serum concentration of paracetamol in naïve 413 
mice confirmed substantial drug uptake after 6 hrs preemptive application (i.e. the 414 
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approximate time point of the ET), and drug levels increased further after 11 and 24 415 
hrs (i.e. correlating with the post-operative phase after ET). In summary, mice 416 
obviously consumed considerable amounts of paracetamol voluntarily with their 417 
drinking water before and after surgery, and the outcome of ET was unaffected by 418 
the treatment. 419 
Paracetamol, also known as acetaminophen, is one of the most widely used 420 
analgesic and antipyretic drugs in human medicine. It is considered safe in 421 
therapeutic dosages to treat fever and pain, and is one of the few pain medications 422 
recommended during pregnancy (de Fays et al., 2015; Thiele et al., 2013). For pain 423 
treatment in adult human patients, dosages of 325–650 mg paracetamol 424 
administered per orally or parenteral every 3–4 hrs (max. 4000 mg within 24h) are 425 
generally considered to be effective and safe. In laboratory mice, doses of 110–305 426 
mg/kg BW (Fish et al., 2008; Flecknell, 1984; Hawk et al., 2005) have been used for 427 
decades. The most common dose recommended by textbooks for pain treatment in 428 
mice is 200 mg paracetamol/kg BW (Flecknell, 2009; Miller and Richardson, 2011). 429 
According to these recommendations, for our study, the amount of paracetamol in 430 
the drinking water was calculated to be 3.5 mg/ml, with the intention to provide the 431 
mice with approximately 200 mg per kg BW. This target dose was reached within 432 
the first 5–6 hrs in some of the naïve mice and surrogate mothers after providing 433 
paracetamol-enriched drinking water. However, several mice stayed beneath the 434 
target dose (104–177 mg/kg BW) of 200 mg/kg BW after 5–6 hrs, i.e. just before the 435 
intended ET. Low water intake during the pre-operative phase could have been due 436 
to the still unfamiliar taste of the water, and to generally lower water intake at the 437 
beginning of the light period. Water consumption during the day time tends to be 438 
less and more sporadic than during night time due to circadian rhythmicity (Sauer 439 
et al., 2016). 440 
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After 11 and 24 hrs, all naïve mice voluntarily consumed more than the target dose. 441 
The consumption of medicated water also increased in surrogate mothers during 442 
the post-surgery treatment phase of 24 and 48 hrs, resulting in an ingested dose 443 
significantly higher than the target dose of 200 mg/kg BW (Figs. 2 and 3). This is 444 
likely to be attributed to the fact that paracetamol was added to the drinking water 445 
as a children’s syrup, which, due to its sweet taste, could have stimulated animals 446 
to drink more than usual, even after surgery. 447 
It is well known that paracetamol can cause severe liver damage when overdosed. 448 
Damage to the liver is not induced by the drug itself but by the build-up of a toxic 449 
metabolite due to oversaturated glucuronidation in the liver (Mattia and Coluzzi, 450 
2009). Due to its hepatotoxic characteristics, paracetamol is used widely in 451 
experimental models of acute liver injury in mice. According to safety data sheets 452 
for paracetamol, the oral lethal dose (LD) 50 in mice is 338 mg/kg BW (see for 453 
example www.caymanchem.com/msdss/10024m.pdf). However, it has been 454 
reported that experimentally induced liver injury is also sex- as well as strain-455 
dependent (Mohar et al., 2014; Mossanen and Tacke, 2015). Male mice seem to be 456 
more susceptible than female mice (Taguchi et al., 2015), and C57BL/6 mice are 457 
more responsive than BALB/c (Mossanen and Tacke, 2015). Mossanen and Tacke 458 
recommend a dose of 300 mg/kg BW paracetamol with i.p. injection after a fasting 459 
period of 12 hrs to reliably induce acute liver injury in mice. Taguchi et al. 460 
administered doses of 300 mg/kg BW or 600 mg/kg BW paracetamol, with i.p. 461 
injection after 12 hrs fasting to induce liver injury in 4- to 12-week-old mice (Taguchi 462 
et al., 2015). Additionally, a recent study showed that pregnant mice were more 463 
sensitive to paracetamol-induced hepatotoxicity (Karimi et al., 2015). In this latter 464 
study, a dose of 250 mg/kg BW paracetamol administered as a single bolus injection 465 
after 16 hrs of fasting at gestation day 12.5 induced hepatocellular injury and 466 
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inflammation, while a dose of 450 mg/kg BW induced lethal effects in pregnant but 467 
not in non-pregnant mice. Although paracetamol administration did not affect the 468 
fetal loss rate, decreased body weights were found in offspring in the prenatal and 469 
neonatal stage (Karimi et al., 2015).  470 
As most of the mice in our study voluntarily consumed, at least during the second 471 
part of the experiment, higher doses than the target dose of 200 mg/kg BW, and in 472 
some cases even more than the highest recommended dose of 305 mg/kg BW, 473 
concern regarding potential liver damage or decreased body weight in offspring due 474 
to accidental overdosing arises. However, studies by Hayes et al. and Christy et al. 475 
revealed no deaths or apparent signs of liver damage or failure even after mice 476 
ingested approx. 320–640 mg/kg BW of paracetamol voluntary via drinking water 477 
(Christy et al., 2014; Hayes et al., 2000).  478 
To elucidate further the potential for over-dosage and subsequent toxic effects from 479 
paracetamol consumption with drinking water in our study, the concentration of 480 
paracetamol in blood serum was determined in naïve mice. In both our control 481 
groups, after i.p. injection or gavage of 200 mg/kg BW as a bolus, serum 482 
concentrations of paracetamol reached 4402.6 ± 1152.3 ng/ml and 5668.5 ± 2208.3 483 
ng/ml, respectively, at 2 hrs after treatment. In contrast, serum concentrations were 484 
significantly lower in all drinking water groups compared to our controls. Here, the 485 
maximum level of 2796.5 ± 1620.0 ng/ml was noted after 24 hrs (PW3). 486 
In human patients, if plasma concentrations 4 hrs after drug intake are lower than 487 
120023 ng/ml (794 µmol/L), toxic liver effects are unlikely to result. If plasma 488 
concentrations are higher than 120023 ng/ml (794 µmol/L), liver insufficiency could 489 
occur, and if plasma concentrations are higher than 300057 ng/ml (1985 µmol/L), 490 
liver necrosis is likely (DRI® Paracetamol-Serum-Tox-Assay). As data for toxic 491 
plasma concentrations in mice are still lacking, we have to rely on data from human 492 
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studies: In our study, serum concentrations of paracetamol after bolus application 493 
as well as after voluntary intake in drinking water, were always far below critical 494 
levels from human tox-assays. Moreover, no cases of death occurred, and no 495 
obvious aberrations in appearance and behaviour of animals were noticed at regular 496 
routine checking. We therefore assume that toxic effects were unlikely at the doses 497 
used. 498 
Additionally, in our study, doses of up to about 600–1000 mg/kg BW paracetamol 499 
per day in the drinking water of mice on days 1 and 2 of gestation did not lead to 500 
any significant impairment of our ET success rate. The number of pups born was 501 
related to the number of transferred two-cell stage embryos, and was not 502 
significantly different between the paracetamol-treated and untreated surrogate 503 
mothers. Although one of the surrogate mothers in the paracetamol treated group 504 
failed to get pregnant while all untreated animals gave birth, the litters of treated 505 
surrogate mothers were on average larger, thus compensating for the lower rate of 506 
pregnancy. In addition, the body weight of newborn pups was comparable after 507 
paracetamol treatment of recipients at 2 days of gestation. Altogether, our results 508 
provided no evidence for any adverse effects of paracetamol treatment on the 509 
overall outcome of ET. 510 
The observed lack of detrimental effects on animal health and ET outcome may be 511 
the result of constant but low intake of the drug via drinking water. Most mice in the 512 
present study consumed high levels of paracetamol; however, the animals ingested 513 
the medication distributed over a time span of up to 2 days rather than as a high 514 
dose bolus after fasting, as carried out in studies to induce liver damage (Corcoran 515 
et al., 1988; Karimi et al., 2015; Mossanen and Tacke, 2015; Taguchi et al., 2015) 516 
or for traditional LD50 determination. Paracetamol reaches peak concentrations at 517 
30–60 minutes after administration, and its half-life in blood plasma is about 2 hrs 518 
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(Flower et al., 1985; Mickley et al., 2006), thus reducing concerns regarding toxicity 519 
in our study. 520 
In the present study, the efficacy of paracetamol in regards to post-operative pain 521 
relief was not investigated. The focus was rather on whether mice would voluntarily 522 
ingest paracetamol-enriched water in amounts sufficient to achieve commonly 523 
recommended doses, and whether the drug had any influence on the success rate 524 
of ET and offspring survival. Both strains of mice (Crl:CD and Zbz:FM) consumed 525 
similar doses of acetaminophen via the drinking water. However, as food and water 526 
intake can differ between strains (Bachmanov et al., 2002), the dosage of 527 
acetaminophen may also need to be adjusted due to strain variation (Dickinson et 528 
al., 2009). Consequently, no evaluation of pain relief can be drawn from the present 529 
study, even though plasma levels of paracetamol were comparable to doses 530 
effective in analgesiometric tests (Qiu et al., 2007). Future studies are needed to 531 
provide evidence for the degree of pain relief after ET with paracetamol, and to 532 
elucidate other possible side-effects of the drug when used for this purpose. 533 
For transferring this protocol to other laboratories, specific conditions of each 534 
country might be considered. It could be necessary to check for availability of 535 
acetaminophen and clarify whether a formulation or commercially available drug is 536 
permitted by regulative authorities for the use in experimental animals. 537 
With regard to surrogate mothers, specifics of strain and age might be considered, 538 
although for ET females in a similar age range and mostly outbred strains are used. 539 
Thus, differences regarding dose-response and toxic effects might be negligible. 540 
This is underpinned by our observation that both outbred strains (Crl:CD and 541 
Zbz:FM) consumed similar amounts of water, i.e. doses of acetaminophen. 542 
Furthermore, the uptake of paracetamol with the drinking water might be decreased 543 
after anaesthesia and surgery, but data obtained in this study and from other 544 
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publications (Cesarovic et al., 2010; Sauer et al., 2016) show, that no relevant 545 
alteration of drinking behaviour occurred after inhalation anaesthesia with or without 546 
surgery. However, in case of doubts regarding uptake of the drug in the immediate 547 
post-anaesthetic phase, one may administer the analgesic then as a single bolus-548 
injection to compensate for a suspected delay in drinking after the intervention.  549 
 550 
5. Conclusions 551 
In summary, the animals in our study ingested voluntarily substantial amounts of 552 
paracetamol with drinking water that allow the assumption of constant post-553 
operative pain treatment. An extension of the preemptive application phase of the 554 
medication in the drinking water or a single i.p. injection of paracetamol might be 555 
necessary to assure target plasma concentration immediately before, and during 556 
the first hours after ET. High doses of paracetamol were reached already several 557 
hours after surgery, supported by the increased consumption of medicated water. 558 
The animals received their medication without stress through handling, restraint, or 559 
manipulation (e.g. frequent injections), all of which could influence their well-being 560 
(Jirkof et al., 2015) and possibly adversely affect pregnancy and the outcome of ET. 561 
Although substantial doses of paracetamol were consumed within 2 days after 562 
surgery, no side-effects on the overall outcome of ET were detected. Therefore, 563 
administering paracetamol in drinking water could be a feasible method for providing 564 
pain relief in mice undergoing ET. 565 
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Legends 598 
Fig. 1: Experimental schedule for surrogate mothers and naïve mice. 599 
Measurements of intake of either untreated (n = 8) or paracetamol-containing water 600 
(n = 7) in surrogate mothers took place at 13:00 and 08:00 (i.e. after 5, 24, 48 hrs). 601 
ET was performed at 5 hrs after the start of the experiment (13:00 – 14:00). 602 
In naïve mice (n = 8 / group), baseline measurements of untreated water intake took 603 
place at 14:00, 19:00 and 08:00 (i.e. after 6, 11, 24 hrs) on the first day. On the 604 
following day, measurements of paracetamol-treated water intake as well as blood 605 
sampling, took place at 14:00, 19:00 and 08:00 (i.e. after 6, 11, 24 hrs).  606 
 607 
 608 
 609 
 610 
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Fig. 2: Comparison of mean water intake per hour with and without 611 
paracetamol in naïve mice. 612 
Paracetamol was provided to naïve mice in their drinking water at a concentration 613 
of 3.5 mg paracetamol per ml water. Baseline measurements for intake of untreated 614 
water were taken the day before. Measurements of water intake was conducted 615 
after 6 hrs in PW1, after 11 hrs in PW2, and at 24 h in PW3 (n = 8 / group). Mean 616 
values (± SD) of water intake in naïve mice with and without paracetamol in drinking 617 
water is traced as ml/h. Bars indicate SD. Significant differences between baseline 618 
and experiment were found in all three groups (PW1: p = 0.017; PW2: p = 619 
0.001;PW3: p = 0.001). * p≤0.05 and ** p≤0.01. 620 
 621 
 622 
 623 
 624 
 625 
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Fig. 3: Comparison of mean water intake per hour with and without 626 
paracetamol in surrogate mothers. 627 
Mean water intake in untreated (n = 8) and paracetamol-treated (n = 7) surrogate 628 
mothers in the 5 hrs before ET, and during 2 days (≤ 42 hrs) after ET. Water intake 629 
was calculated as ml/h. Bars indicate SD. A significant difference was found 630 
between treated and untreated groups on the first (18 hrs post ET, p = 0.023) and 631 
second (42 hrs post ET, p = 0.008) day after ET. * p≤0.05 and ** p≤0.01. 632 
 633 
 634 
 635 
 636 
 637 
 638 
 639 
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Fig. 4: Individual serum concentrations of paracetamol in naïve mice. 640 
In PW groups, paracetamol was provided to naïve mice in their drinking water at a 641 
concentration of 3.5 mg paracetamol per ml water. Blood serum was taken after 6 642 
hrs in PW1, after 11 hrs in PW2, and at 24 hrs in PW3. In control groups, 643 
paracetamol was administered as bolus at a dose of 200 mg/kg BW by 644 
intraperitoneal injection (I) or gavage (G). Blood was sampled at 2 hrs after bolus 645 
application. 646 
Individual serum concentrations for all groups (n = 8 / group) are depicted as one 647 
dot for each mouse. 648 
 649 
 650 
 651 
 652 
 653 
 654 
 655 
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Table 1: Outcome of ET. 656 
One surrogate mother of the paracetamol-treated group was not visibly pregnant 657 
and did not give birth, but was included in the calculation of data. Statistical 658 
comparison of litter size and offspring weight showed no significant difference 659 
whether surrogate mothers received paracetamol or not with their drinking water for 660 
48 hrs (success rate: p = 0.864, body weight in newborn offspring: p = 0.330). 661 
 662 
     
  
without 
treatment    with paracetamol   
number of foster mothers used 
for ET 8   7   
total number of two cell embryos 
transferred 96   84   
number of pregnant females at 
day 9 and 12 of gestation 8   6   
number of litters 8   6   
total number of offsprings 35   32   
mean litter size 4.38 (±1.60)   4.57 (±2.70)   
relation between live offsprings  
and  transferred two cell embryos 
(success rate) 35/96 (36%)   32/84  (38%)   
mean offspring body weight at 
birth [g], (±SD) 1.90 (±0.19) n=35 1.86 (±0.14) n=32 
     
     
     
 663 
 664 
 665 
 666 
 667 
 668 
 669 
 670 
 671 
 672 
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